Transport Delivers Unprecedented Levels Of Acyclovir With Novel Five Percent Gel Formulation

... Transport Pharmaceuticals, Inc., a leader in combination drug/medical devices for the topical treatment of dermatological conditions, today announced preliminary results from a recently completed Phase I safety and pharmacokinetic study with the SoloVir(TM) electrokinetic transdermal system, being developed for the treatment of herpes labialis, or cold sores. [click link for full article] ...